STOCK TITAN

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced that its management team will participate in two upcoming investor conferences: Jefferies London Healthcare Conference on November 15, 2023, in London, and Evercore ISI 6th Annual HealthCONx Conference on November 28, 2023, in Miami, FL. Access to live webcasts and archived recordings will be available on the company's investor relations website.
Positive
  • None.
Negative
  • None.

BOSTON and LONDON, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:

Event: Jefferies London Healthcare Conference
Date: November 15, 2023
Location: London
Fireside Chat: 10:30 AM BST

Event: Evercore ISI 6th Annual HealthCONx Conference
Date: November 28, 2023
Location: Miami, FL
Fireside Chat: 4:40 PM ET

Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.

About Centessa Pharmaceuticals 
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit www.centessa.com, which does not form part of this release.

Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com


FAQ

What is the company name mentioned in the press release?

The company mentioned in the press release is Centessa Pharmaceuticals plc.

What is the stock symbol of Centessa Pharmaceuticals?

The stock symbol of Centessa Pharmaceuticals is Nasdaq: CNTA.

When and where will the Jefferies London Healthcare Conference take place?

The Jefferies London Healthcare Conference will take place on November 15, 2023, in London.

When and where will the Evercore ISI 6th Annual HealthCONx Conference take place?

The Evercore ISI 6th Annual HealthCONx Conference will take place on November 28, 2023, in Miami, FL.

Where can I access the live webcasts and archived recordings of these events?

You can access the live webcasts and archived recordings of these events on the Centessa Pharmaceuticals investor relations website under the 'Events and Publications' tab.

Centessa Pharmaceuticals plc American Depositary Shares

NASDAQ:CNTA

CNTA Rankings

CNTA Latest News

CNTA Stock Data

1.06B
43.89M
2.33%
84.02%
1.73%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
ALTRINCHAM, CHESHIRE

About CNTA

centessa pharmaceuticals plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. the company applies an asset-centric r&d model at scale to advance a portfolio of highly validated programs led by industry leading teams. each program is developed by a centessa subsidiary and supported by a centralized infrastructure and the centessa management team. the company is headquartered in cambridge, mass.